Financial statements Laboratorium Diagnostyki Molekularnej
Balance sheet data of LABORATORIUM DIAGNOSTYKI MOLEKULARNEJ
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 77 806,29 | 112 916,71 | 126 148,29 | 383 434,01 | 404 616,79 | 446 280,53 |
| A. Fixed assets | 7 791,94 | 2 178,22 | 11 666,65 | 96 066,61 | 48 466,57 | 5 999,90 |
| B. Current assets | 70 014,35 | 110 738,49 | 114 481,64 | 287 367,40 | 356 150,22 | 440 280,63 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 77 806,29 | 112 916,71 | 126 148,29 | 383 434,01 | 404 616,79 | 446 280,53 |
| A. Equity | 34 066,11 | 32 520,98 | 72 533,05 | 347 377,29 | 368 306,25 | 407 791,90 |
| B. Liabilities and provisions for liabilities | 43 740,18 | 80 395,73 | 53 615,24 | 36 056,72 | 36 310,54 | 38 488,63 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | - | 79 983,43 | 53 615,24 | 35 848,42 | 36 310,54 | 38 488,63 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.